Viewmont
1 month ago
BRANFORD, Conn. , Feb. 3, 2025 /PRNewswire/ -- Azitra, Inc.(AZTR) , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the company will present at the BIO CEO & Investor Conference being held February 10-11, 2025, in New York City.
Azitra Logo (PRNewsfoto/Azitra, Inc.)
herbied47
6 months ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3